ND

Nicholas Downing

Managing Director at Bain Capital

Greater Boston

Overview 

Nicholas Downing is a Managing Director at Bain Capital Life Sciences with a background in medicine from Brigham and Women's Hospital and Yale School of Medicine. He has extensive experience in management consulting at McKinsey & Company and a diverse internship background in research and development. Nicholas has successfully transitioned from a medical career to a leadership role in finance, demonstrating a strong ability to leverage his diverse skill set in investments and strategic planning. His current role at Bain Capital Life Sciences showcases his expertise in healthcare investments and strategic decision-making.

Work Experience 

  • Managing Director

    2023 - Current

  • Principal

    2020 - 2022

  • Associate

    2018 - 2020

Bain Capital is an alternative investment firm specializing in private equity, venture capital, and credit products.

  • Resident Physician

    2015 - 2018

    - Direct patient care on teaching services that include the general medical, cardiology and oncology wards and the intensive care unit. Outpatient care at various sites. - Supervision of junior resident physicians. - Teaching students at Harvard Medical School. - Scholarly work focusing on hospital quality and drug regulation.

  • Post-Doctoral Associate

    2014 - 2015

    Scholarly research in the following areas: - Health services research: U.S. hospital performance and disparities in inpatient care. - Regulation: Drug and device regulation in the U.S. and Europe. - Big Data: Application of novel analytic methods to various clinical and health policy problems. - China: Hospital performance for cardiovascular care.

  • Engagement Manager

    2009 - 2010

  • Business Analyst

    2007 - 2009

McKinsey Growth Tech serves leading growth stage tech players, venture capital, and growth private equity

  • Summer Research Intern

    2006 - 2006

    Molecular biology research in the lab of Dr. Robert Fisher. Studied the role of cyclin dependent kinases in cell cycle control.

  • Research and Development Intern

    2005 - 2005

    Worked on a independent research project in synthetic organic chemistry methodology. Co-authored a paper that is being reviewed at Tetrahedron Letters.

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

Raised $28,500,000,000.00 from Citibank and Bank of America.

  • Summer Intern

    2004 - 2004

    Worked as an intern on the dollar rates derivatives desk.

Morgan Health is the healthcare investment arm of JPMorgan Chase.

Articles About Nicholas

Relevant Websites